An update of novel screening methods for GPCR in drug discovery

By Chen Linjie   Jin Lili   Zhou Naiming  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 9, 2012-09 ,pp. : 791-806

Informa Healthcare

Access to resources Recommend Favorite

In silico Studies Toward the Discovery of Novel Type-II Inhibitors of TrkA: Pharmacophore-based 3D-QSAR Modeling, Database Screening and Molecular Docking

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite

Automated docking for novel drug discovery

By Bello Martiniano   Martínez-Archundia Marlet   Correa-Basurto José  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 7, 2013-08 ,pp. : 821-834

Informa Healthcare

Access to resources Recommend Favorite

In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening

By  

Medicinal Chemistry, Vol. 11, Iss. 7, 2015-01 ,pp. : 687-700

Bentham Science Publishers

Access to resources Recommend Favorite

Homology Modeling and Molecular Docking Studies of Bacillomycin and Iturin Synthetases with Novel Ligands for the Production of Therapeutic Lipopeptides

By  

Current Drug Discovery Technologies, Vol. 15, Iss. 2, 2018-04 ,pp. : 132-141

Bentham Science Publishers

Access to resources Recommend Favorite